People

Philippe Monteyne

Philippe Monteyne is a Neurologist and holds a PhD in viral immunology from the Catholic University of Louvain and a postdoctoral degree in neuroimmunology from the Pasteur Institute in Paris. Dr. Monteyne is Senior Advisor for Life Sciences at AltamarCAM Partners, which has investments of more than 20.8 billion euros in private markets, and a member of the Investment Committee, former partner of their life science fund Aliath Bioventures in Barcelona, and a previous senior partner of Fund+, a private equity fund in Belgium. Philippe's career in the pharmaceutical industry includes senior roles at SmithKline Beecham, GSK, and Sanofi, where he led significant projects such as the development and launch of GSK's Cervical Cancer Vaccine, Cervarix, and innovative therapies like Strimvelis and Tegsedi for rare diseases. His leadership extends to serving on various biotech boards in Belgium, France, and Spain. Philippe is also dedicated to academia, having been a visiting Professor of Neurology at the Université Catholique de Louvain, and continues to inspire future leaders as a part-time Professor and course coordinator of an Advanced Master in Biotech & MedTech Ventures at Solvay Management School, Brussels. His commitment to advancing medical solutions is evident in his strategic roles and contributions to various health organizations.